Vertex Pharmaceuticals Inc

NASDAQ: VRTX
$464.92
-$12.98 (-2.7%)
Closing Price on September 20, 2024

VRTX Articles

The major US stock indexes opened lower this morning following a weekend of elections in Europe. A new Socialist party president in France and a still very cloudy future in Greece have left investors...
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is trading up so much higher that you might think the company is being acquired.  The real reason for the huge share gains is based upon results of...
Jon OggThese are some of today’s top analyst upgrades, downgrades and initiations seen in Wall Street research calls this Tuesday. Achillion Pharmaceuticals Inc. (NASDAQ: ACHN) Started as...
News from Abbott Laboratories (NYSE: ABT) on its positive Phase II study results from two different interferon-free hepatitis C treatment has the entire drug sector up in arms as it pertains to...
Earnings season is still upon us.  There are going to be many big earnings reports Thursday and we would consider Thursday as the climax for the companies reporting their normal fourth quarter...
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Wednesday morning. Amazon.com Inc. (NASDAQ: AMZN) Maintained...
For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at least some of the same problems of Big Pharma players like Pfizer Inc. (NYSE: PFE)...
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning. Altria Group Inc. (NYSE: MO) Cut to Hold at Stifel...
Each morning 24/7 Wall St. issues a summary list of key analyst upgrades, downgrades, and initiations issued by Wall Street research firms.  We review these calls and other calls made throughout the...